Table 1. Patient cohort.

Age, median (range)	68 (26–90)
Sex, n (%)
Female	12 (28)
Male	31 (72)
Pre-treatment staging n (%)
T1, 2	3 (7.0)
T3, 4	40 (93.0)
N0	13 (30.2)
N1, 2	30 (69.8)
Stage I, II	13 (30.2)
Stage III	30 (69.8)
Post-treatment staging, n (%)
ypT1, 2	21 (48.8)
ypT3, 4	22 (51.2)
ypN0	30 (69.8)
ypN1, 2	13 (30.2)
Stage 0	4 (9.3)
Stage I, II	26 (60.5)
Stage III	13 (30.2)